India's Pharmaceutical Exports

Country Profile

Turkey

Turkey is a major destination for Indian pharmaceutical exports — $271M in FY 2025–26, with 2.2× growth over the past decade. Medicine Ingredients accounts for 53% of shipments, with vaccines contributing $45.8M. The compound annual growth rate since FY2015 stands at 7.2%.

🇹🇷 #22 Destination · $271M · 2.2× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$271M
Exports FY2025–26 DGCIS
2.2×
Growth FY2015→2026
0.9%
Share of India Total
#22
Rank Among 178 Markets
7.2%
CAGR FY2015→2026
Turkey is a major destination for Indian pharmaceutical exports — $271M in FY 2025–26, with 2.2× growth over the past decade. Medicine Ingredients accounts for 53% of shipments, with vaccines contributing $45.8M. The compound annual growth rate since FY2015 stands at 7.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $142M (52.5%) Medicines $61.9M (22.8%) Vaccines $45.8M (16.9%) Surgical & Hospital Supplies $19.0M (7.0%) Traditional & Herbal $2.00M (0.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Turkey in the RBI overseas direct investment dataset (2011–2026).